Dr. Petros Papagerakis B.D.S., M.Sc., Ph.D.

Research interests
Dr. Papagerakis’ research interests are in the field of Precision Health applied in oral diseases pathogenesis and treatment, and in the area of dental tissue repair and regeneration using novel dental biomaterials and/or stem cells. Of particular interest is the study of the effects of circadian rhythms disruption and environmental exposure to carcinogenic molecules in relation with saliva biomarker development and the development of targeted personalized treatment for patients with Sjögrens Syndrome (the second most common autoimmune disease) and Oral Cancer (one of the major cancers with very poor survival rate). A second particular interest is in the area of Community and Preventive Health and the development of interventional strategies and the design and implementation of pre-clinical testing and clinical trials of novel biomaterials to prevent and treat dental infectious diseases.

Funding Success in 2017
Dr. Petros Papagerakis is recipient of one of the three 2017 International Innovation Awards from the International Association for Dental Research (IADR) which is the most prestigious award in the field of Oral Health Research Innovation. The award comes with a $50,000 USD grant from GlaxoSmithKline Pharmaceuticals (GSK) to advance innovation to the next stage. Dr. Petros Papagerakis is also awarded this year with a highly competitive R21 award from the US National Institute of Health (NIH) in the area of precision medicine together with Drs. Silvana Papagerakis and Nikos Chronis also PIs of this project. He is also the recipient of a 2017 SHRF Establishment grant.